Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7334

1.

When is dual bronchodilation indicated in COPD?

Thomas M, Halpin DM, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2291-2305. doi: 10.2147/COPD.S138554. eCollection 2017. Review.

PMID:
28814857
2.

1300PBUPARLISIB (BKM120) IN PATIENTS WITH PI3K PATHWAY-ACTIVATED, METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM THE BASALT-1 STUDY.

Soria JC, Vansteenkiste JF, Canon J, Reck M, Gridelli C, Grossi F, De Pas T, Gray J, Felip E, Su W, Yoshioka H, Dy GK, Thomas M, De Greve J, Roussou P, Atalla-Vidam G, Aimone P, Thongprasert S.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv458-iv459. doi: 10.1093/annonc/mdu349.79. No abstract available.

PMID:
28172321
3.

1293PEVALUATION OF CERITINIB-TREATED PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES IN THE ASCEND-1 STUDY.

Shaw AT, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste JF, Sharma S, De Pas T, Riely GJ, Solomon B, Wolf J, Thomas M, Schuler M, Liu G, Santoro A, Geraldes M, Boral AL, Yovine A, Kim D.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv455-iv456. doi: 10.1093/annonc/mdu349.72. No abstract available.

PMID:
28172271
4.

1295PEFFICACY AND SAFETY OF CERITINIB IN PATIENTS (PTS) WITH ADVANCED ANAPLASTIC LYMPHOMA KINASE (ALK)-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC): AN UPDATE OF ASCEND-1.

Felip E, Kim D, Mehra R, Tan DS, Chow LQ, Camidge DR, Vansteenkiste JF, Sharma S, De Pas T, Riely GJ, Solomon B, Wolf J, Thomas M, Schuler M, Lui G, Santoro A, Geraldes M, Boral AL, Yovine A, Shaw AT.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv456-iv457. doi: 10.1093/annonc/mdu349.74. No abstract available.

PMID:
28172092
5.

1071PCHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) WITH IMPRIME PGG (IPGG) IN COMBINATION WITH CETUXIMAB, CARBOPLATIN AND PACLITAXEL-ANALYSIS OF SECONDARY ENDPOINTS OF A MULTICENTER, RANDOMIZED PHASE 2 TRIAL.

Schneller F, Thomas M, Sadjadian P, Kollmeier J, Bose N, Patchen ML, Lowe J, Mattson P, Gargano M, Huhn RD, Braun A.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv369. doi: 10.1093/annonc/mdu342.24. No abstract available.

PMID:
28171513
6.

1266PQUALITY OF LIFE (QOL) RESULTS FROM THE PHASE 3 REVEL STUDY OF RAMUCIRUMAB + DOCETAXEL (RAM + DTX) VERSUS PLACEBO + DOCETAXEL (PL + DTX) IN ADVANCED/METASTATIC NSCLC PATIENTS (PTS) WITH PROGRESSION AFTER PLATINUM BASED CHEMOTHERAPY.

Garon EB, Ciuleanu T, Arrieta O, Prabhash K, Syrigos KN, Göksel T, Park K, Kowalyszyn R, Pikiel J, Lewanski C, Thomas M, Dakhil S, Kim J, Karaseva N, Yurasov S, Zimmermann A, Carter GC, Reck M, Cappuzzo F, Perol M.

Ann Oncol. 2014 Sep 1;25(suppl_4):iv445. doi: 10.1093/annonc/mdu349.45. No abstract available.

PMID:
28171294
7.

PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).

De Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral Jaime J, Melemed S, John WJ, Chouaki N, Zimmermann A, Visseren-Grul C, Gridelli C.

J Clin Oncol. 2012 Jun 20;30(18_suppl):LBA7507. doi: 10.1200/jco.2012.30.18_suppl.lba7507.

PMID:
28140806
8.

Modulation of Glutathione Hemostasis by Inhibition of 12/15-Lipoxygenase Prevents ROS-Mediated Cell Death after Hepatic Ischemia and Reperfusion.

Drefs M, Thomas MN, Guba M, Angele MK, Werner J, Conrad M, Steib CJ, Holdt LM, Andrassy J, Khandoga A, Rentsch M.

Oxid Med Cell Longev. 2017;2017:8325754. doi: 10.1155/2017/8325754. Epub 2017 Jul 24.

9.

Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.

Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW, Moss S, Hackshaw A, Halloran S, Kralj-Hans I, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas M, Counsell N, von Wagner C.

BMC Cancer. 2017 Aug 14;17(1):543. doi: 10.1186/s12885-017-3512-1.

10.

Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines.

Linossier MT, Amirova LE, Thomas M, Normand M, Bareille MP, Gauquelin-Koch G, Beck A, Costes-Salon MC, Bonneau C, Gharib C, Custaud MA, Vico L.

PLoS One. 2017 Aug 14;12(8):e0182970. doi: 10.1371/journal.pone.0182970. eCollection 2017.

11.

β-Functionalized Push-Pull Opp-Dibenzoporphyrins as Sensitizers for Dye-Sensitized Solar Cells.

Wang H, Hu Y, Yellappa S, Thomas MB, Jinadasa RGW, Matus A, Shulman M, D'souza F.

Chem Asian J. 2017 Aug 11. doi: 10.1002/asia.201701117. [Epub ahead of print]

PMID:
28800197
12.

Specialist Peri-Operative Allergy Clinic Services in the UK 2016: Results from the Royal College of Anaesthetists Sixth National Audit Project (NAP6).

Egner W, Cook T, Harper N, Garcez T, Marinho S, Kong KL, Nasser S, Thomas M, Warner A, Hitchman J, Floss K.

Clin Exp Allergy. 2017 Aug 8. doi: 10.1111/cea.12993. [Epub ahead of print]

PMID:
28787764
13.

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.

Ciuleanu TE, Ahmed S, Kim JH, Mezger J, Park K, Thomas M, Chen J, Poondru S, VanTornout JM, Whitcomb D, Blackhall F.

Br J Cancer. 2017 Aug 3. doi: 10.1038/bjc.2017.226. [Epub ahead of print]

PMID:
28772281
14.

Sequence-Dependent Self-Assembly and Structural Diversity of Islet Amyloid Polypeptide-Derived β-Sheet Fibrils.

Wang ST, Lin Y, Spencer RK, Thomas MR, Nguyen AI, Amdursky N, Pashuck ET, Skaalure SC, Song CY, Parmar PA, Morgan RM, Ercius P, Aloni S, Zuckermann RN, Stevens MM.

ACS Nano. 2017 Aug 3. doi: 10.1021/acsnano.7b02325. [Epub ahead of print]

PMID:
28771324
15.

Fertilization Shapes Bacterial Community Structure by Alteration of Soil pH.

Zhang Y, Shen H, He X, Thomas BW, Lupwayi NZ, Hao X, Thomas MC, Shi X.

Front Microbiol. 2017 Jul 18;8:1325. doi: 10.3389/fmicb.2017.01325. eCollection 2017.

16.

Demographic and dietary risk factors in relation to urinary metabolites of organophosphate flame retardants in toddlers.

Thomas MB, Stapleton HM, Dills RL, Violette HD, Christakis DA, Sathyanarayana S.

Chemosphere. 2017 Oct;185:918-925. doi: 10.1016/j.chemosphere.2017.07.015. Epub 2017 Jul 4.

PMID:
28763939
17.

Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

Thomas MP, Bates ER.

Curr Opin Cardiol. 2017 Jul 29. doi: 10.1097/HCO.0000000000000446. [Epub ahead of print]

PMID:
28759470
18.

Intervention for children with word-finding difficulties: a parallel group randomised control trial.

Best W, Hughes LM, Masterson J, Thomas M, Fedor A, Roncoli S, Fern-Pollak L, Shepherd DL, Howard D, Shobbrook K, Kapikian A.

Int J Speech Lang Pathol. 2017 Jul 31:1-12. doi: 10.1080/17549507.2017.1348541. [Epub ahead of print]

PMID:
28756691
19.

Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.

Maag J, Fisher OM, Levert-Mignon AJ, Kaczorowski DC, Thomas ML, Hussey D, Watson D, Wettstein A, Bobryshev YV, Edwards M, Dinger ME, Lord RV.

Mol Cancer Res. 2017 Jul 27. pii: molcanres.0332.2017. doi: 10.1158/1541-7786.MCR-17-0332. [Epub ahead of print]

PMID:
28751461
20.

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study.

de Castro J, Tagliaferri P, de Lima VCC, Ng S, Thomas M, Arunachalam A, Cao X, Kothari S, Burke T, Myeong H, Grattan A, Lee DH.

Eur J Cancer Care (Engl). 2017 Jul 27. doi: 10.1111/ecc.12734. [Epub ahead of print]

PMID:
28748556

Supplemental Content

Loading ...
Support Center